Cargando…

Higher serum levels of tumour necrosis factor and its soluble receptors are associated with ovarian tumours

INTRODUCTION: Tumour necrosis factor (TNF) and its soluble receptors type 1 (sTNF-R1) and type 2 (sTNF-R2) have been suggested as key mediators between apoptosis and cancer cell progression. The aim was to examine concentrations of the parameters in the serum of women with ovarian tumour and in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mielczarek-Palacz, Aleksandra, Kondera-Anasz, Zdzisława, Sikora, Justyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2012
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506230/ https://www.ncbi.nlm.nih.gov/pubmed/23185194 http://dx.doi.org/10.5114/aoms.2012.31384

Ejemplares similares

Assessment of concentrations of sTRAIL ligand and its receptors sTRAIL-R1 and sTRAIL-R2 – markers monitoring the course of the extrinsic pathway of apoptosis induction: potential application in ovarian cancer diagnostics
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2015)

Changes in the Concentration of Markers Participating in the Regulation of the Apoptosis Receptor Pathway Involving Soluble Tumour Necrosis Factor Ligand Inducing Apoptosis (sTRAIL) and Osteoprotegerin (OPG) in the Serum of Women with Ovarian Cancer—Participation in Pathogenesis or a Possible Clinical Use?
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2020)

Participation of Selected Soluble BMP-2 and BMP-7 Bone Morphogenetic Proteins and Their Soluble Type I ALK-1 and Type II BMPR2 Receptors in Formation and Development of Endometriosis
por: Janusz, Joanna, et al.
Publicado: (2021)

Effect of Th1/Th2 cytokine administration on proinflammatory SKOV-3 cell activation
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2015)

The role of complement components C1q, MBL and C1 inhibitor in pathogenesis of endometriosis
por: Sikora, Justyna, et al.
Publicado: (2018)

The role of galectins-1, 3, 7, 8 and 9 as potential diagnostic and therapeutic markers in ovarian cancer
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2022)

Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
por: Glossop, John R, et al.
Publicado: (2005)

Postchemoembolisation syndrome – tumour necrosis or hepatocyte injury?
por: Wigmore, S J, et al.
Publicado: (2003)

Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2.
por: Miles, D. W., et al.
Publicado: (1992)

Soluble tumour necrosis factor receptor type II and survival in colorectal cancer
por: Babic, Ana, et al.
Publicado: (2016)

Evaluation of the Potential Diagnostic Utility of the Determination of Selected Immunological and Molecular Parameters in Patients with Ovarian Cancer
por: Englisz, Aleksandra, et al.
Publicado: (2023)

Evaluation of the Potential Diagnostic Utility of the Determination of Selected Caspases—Markers Involved in the Regulation of Apoptosis—In Patients with Ovarian Cancer
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2021)

Soluble tumour necrosis factor receptor I is a promising early indicator of complicated clinical outcome in patients following severe trauma
por: BINKOWSKA, ANETA M., et al.
Publicado: (2020)

The Assessment of IL-21 and IL-22 at the mRNA Level in Tumor Tissue and Protein Concentration in Serum and Peritoneal Fluid in Patients with Ovarian Cancer
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2021)

Factors affecting the concentration of soluble tumour necrosis factor-α receptor type I in the blood serum of patients with localized scleroderma
por: Zbiciak-Nylec, Martyna, et al.
Publicado: (2020)

Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients.
por: Warzocha, K., et al.
Publicado: (1998)

The Role of Selected Adipocytokines in Ovarian Cancer and Endometrial Cancer
por: Stępień, Sebastian, et al.
Publicado: (2023)

Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumours.
por: Lissoni, P., et al.
Publicado: (1989)

Analysis of CXCL8 and its receptors CXCR1/CXCR2 at the mRNA level in neoplastic tissue, as well as in serum and peritoneal fluid in patients with ovarian cancer
por: Smycz-Kubańska, Marta, et al.
Publicado: (2022)

Tumour necrosis factor gene polymorphisms and migraine in Greek children
por: Pappa, Styliani, et al.
Publicado: (2010)

Clinical impact and network of determinants of tumour necrosis in colorectal cancer
por: Väyrynen, Sara A, et al.
Publicado: (2016)

The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
por: Harrold, Leslie R, et al.
Publicado: (2015)

Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor.
por: Trentin, L., et al.
Publicado: (1995)

Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review)
por: Królewska-Daszczyńska, Patrycja, et al.
Publicado: (2022)

Tumour necrosis factor-alpha, interleukin-2 soluble receptor and different inflammatory parameters in patients with rheumatoid arthritis.
por: Fröde, Tânia Silvia, et al.
Publicado: (2002)

Depressed female smokers have higher levels of soluble tumor necrosis factor receptor 1
por: Porcu, Mauro, et al.
Publicado: (2018)

Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor γ in epithelial ovarian tumours
por: Sakamoto, A, et al.
Publicado: (2004)

Serial measurement of the circulating levels of tumour necrosis factor and its soluble receptors 1 and 2 for monitoring leprosy patients during multidrug treatment
por: Costa, Rosane Dias, et al.
Publicado: (2013)

The Role of Costimulatory Receptors of the Tumour Necrosis Factor Receptor Family in Atherosclerosis
por: Antunes, Ricardo F., et al.
Publicado: (2012)

Association of soluble interleukin‐2 receptor α and tumour necrosis factor receptor 1 with heart failure: The Multi‐Ethnic Study of Atherosclerosis
por: Bakhshi, Hooman, et al.
Publicado: (2020)

Serum soluble transferrin receptor levels are independently associated with homeostasis model assessment of insulin resistance in adolescent girls
por: Klisic, Aleksandra, et al.
Publicado: (2021)

Interleukin-6, tumour necrosis factor α and interleukin-1β in patients with renal cell carcinoma
por: Yoshida, N, et al.
Publicado: (2002)

Effects of Endurance Training on the Serum Levels of Tumour Necrosis Factor-α and Interferon-γ in Sedentary Men
por: Jahromi, Abdolreza Sotoodeh, et al.
Publicado: (2014)

Polymorphisms in Tumour Necrosis Factor Alpha (TNFα) Gene in Patients with Acute Pancreatitis
por: Özhan, Gül, et al.
Publicado: (2010)

Clinical outcome and risk factors for recurrence in borderline ovarian tumours
por: Yokoyama, Y, et al.
Publicado: (2006)

MicroRNAs as Potential Biomarkers in Gynecological Cancers
por: Miśkiewicz, Joanna, et al.
Publicado: (2023)

The Relationship of Fever to Tumour Necrosis in the Rat
por: Allen, Ingrid V.
Publicado: (1964)

Tumour Necrosis Factor-Α, Interleukin-1 and Interleukin-6 Serum Levels and Its Correlation with Pain Severity in Chronic Tension-Type Headache Patients: Analysing Effect of Dexketoprofen Administration
por: Rambe, Aldy Safruddin, et al.
Publicado: (2017)

Expression of tumour necrosis factor alpha and its receptors in carcinoma of the breast.
por: Pusztai, L., et al.
Publicado: (1994)

Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis
por: Takeuchi, Tsutomu, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_deu2up7h4rqenq0im1rpcsh4jm